Veradigm® · 5 days ago
Associate Sales Development Specialist - Ambulatory Inside Sales - Remote
Veradigm is focused on transforming healthcare by harnessing research, analytics, and artificial intelligence. They are seeking an Associate Sales Development Specialist to engage with prospective ambulatory customers, generate interest in their solutions, and contribute to revenue growth through effective lead qualification and outreach efforts.
Electronic Health Record (EHR)Health CareHospitalInformation ServicesInformation Technology
Responsibilities
Educate medical professionals on Veradigm products and services
Qualify inbound sales leads according to the established campaign criteria and definitions
Update the CRM application requirements based on prospect engagement
Maintain high levels of professionalism and engagement
Help drive Veradigm revenue growth by connecting prospective customers to valuable products, services and partner solutions by meeting or exceeding weekly call quota and contract targets
Cultivate and qualify new leads that turn into quality appointments and closed opportunities for Veradigm sales
Qualification
Required
Bachelor's Degree or equivalent Physician Practice office / sales / business development experience
Comfortable with CRM systems and documenting call outcomes
self-motivated
detailed oriented
drive to succeed
positive and supportive personality
Preferred
1-2 years relevant work experience preferred
Benefits
Holidays
Vacation
Medical
Dental
Vision insurance
Company paid life insurance
Retirement savings
Company
Veradigm®
Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery—these stakeholders include biopharma, health plans, healthcare providers, network partners, and most importantly, the patients they serve.
Funding
Current Stage
Public CompanyTotal Funding
$175MKey Investors
NantCapital
2025-06-18Post Ipo Debt· $75M
2015-06-30Post Ipo Equity· $100M
2008-03-18Acquired
Recent News
2025-12-16
2025-11-11
Company data provided by crunchbase